PhaseBio Pharmaceuticals Inc (PHAS) is near the bottom in its sector according to InvestorsObserver. PHAS gets an overall rating of 13. That means it scores higher than 13% of stocks. PhaseBio Pharmaceuticals Inc gets a 26 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.
PHAS has an Overall Score of 13. Find out what this means to you and get the rest of the rankings on PHAS!